DiaMedica Therapeutics Inc. (DMAC)
NASDAQ: DMAC · Real-Time Price · USD
5.16
-0.06 (-1.15%)
Aug 13, 2025, 9:56 AM - Market open
DiaMedica Therapeutics Analyst Ratings
Total Analysts
4
Consensus Rating
Strong Buy
Price Target
$10.75
Upside
+108.33%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Craig-Hallum | Craig-Hallum | Strong Buy Maintains $8 → $11 | Strong Buy | Maintains | $8 → $11 | +113.18% | Jul 18, 2025 |
| Lake Street | Lake Street | Strong Buy Maintains $11 → $14 | Strong Buy | Maintains | $11 → $14 | +171.32% | Jul 18, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $10 → $12 | Strong Buy | Maintains | $10 → $12 | +132.56% | Jul 18, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +93.80% | May 29, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $7 → $10 | Strong Buy | Maintains | $7 → $10 | +93.80% | Mar 19, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +35.66% | Nov 15, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +35.66% | Oct 10, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $7 | Strong Buy | Initiates | $7 | +35.66% | Oct 7, 2024 |
| Oppenheimer | Oppenheimer | Buy Reiterates $6 | Buy | Reiterates | $6 | +16.28% | Aug 16, 2024 |
| Craig-Hallum | Craig-Hallum | Strong Buy Initiates $8 | Strong Buy | Initiates | $8 | +55.04% | Apr 24, 2024 |
| Craig-Hallum | Craig-Hallum | Strong Buy Maintains $11 → $8 | Strong Buy | Maintains | $11 → $8 | +55.04% | Mar 21, 2024 |
| Oppenheimer | Oppenheimer | Buy Reiterates $7 → $6 | Buy | Reiterates | $7 → $6 | +16.28% | Mar 21, 2024 |
| Oppenheimer | Oppenheimer | Hold → Buy Upgrades $7 | Hold → Buy | Upgrades | $7 | +35.66% | Jun 22, 2023 |
| Lake Street | Lake Street | Strong Buy Maintains $14 → $8 | Strong Buy | Maintains | $14 → $8 | +55.04% | Jul 7, 2022 |
| Craig-Hallum | Craig-Hallum | Strong Buy Maintains $18 → $12 | Strong Buy | Maintains | $18 → $12 | +132.56% | Jul 7, 2022 |
| Oppenheimer | Oppenheimer | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Jul 7, 2022 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.